Arden Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.52M | Sell |
3,886
-289
| -7% | -$231K | 0.49% | 38 |
|
|
2024
Q1 | $3.25M | Sell |
4,175
-109
| -3% | -$77.6K | 0.45% | 41 |
|
|
2023
Q4 | $2.5M | Sell |
4,284
-369
| -8% | -$215K | 0.37% | 45 |
|
|
2023
Q3 | $2.5M | Buy |
4,653
+35
| +0.8% | +$18K | 0.42% | 45 |
|
|
2023
Q2 | $2.17M | Sell |
4,618
-91
| -2% | -$38.2K | 0.36% | 47 |
|
|
2023
Q1 | $1.62M | Sell |
4,709
-336
| -7% | -$113K | 0.29% | 72 |
|
|
2022
Q4 | $1.85M | Sell |
5,045
-311
| -6% | -$110K | 0.37% | 64 |
|
|
2022
Q3 | $1.73M | Sell |
5,356
-1,249
| -19% | -$396K | 0.44% | 55 |
|
|
2022
Q2 | $2.14M | Sell |
6,605
-905
| -12% | -$272K | 0.49% | 56 |
|
|
2022
Q1 | $2.15M | Sell |
7,510
-1,472
| -16% | -$379K | 0.42% | 53 |
|
|
2021
Q4 | $2.48M | Sell |
8,982
-1,230
| -12% | -$312K | 0.42% | 51 |
|
|
2021
Q3 | $2.36M | Sell |
10,212
-1,435
| -12% | -$354K | 0.4% | 52 |
|
|
2021
Q2 | $2.67M | Sell |
11,647
-2,149
| -16% | -$432K | 0.44% | 46 |
|
|
2021
Q1 | $2.58M | Sell |
13,796
-450
| -3% | -$88K | 0.43% | 41 |
|
|
2020
Q4 | $2.4M | Hold |
14,246
| – | – | 0.4% | 45 |
|
|
2020
Q3 | $2.11M | Sell |
14,246
-100
| -0.7% | -$15.5K | 0.38% | 50 |
|
|
2020
Q2 | $2.35M | Sell |
14,346
-495
| -3% | -$76K | 0.43% | 43 |
|
|
2020
Q1 | $2.06M | Sell |
14,841
-2,698
| -15% | -$371K | 0.41% | 41 |
|
|
2019
Q4 | $2.31M | Buy |
17,539
+1,599
| +10% | +$185K | 0.36% | 57 |
|
|
2019
Q3 | $1.78M | Sell |
15,940
-107
| -0.7% | -$11.9K | 0.29% | 77 |
|
|
2019
Q2 | $1.78M | Sell |
16,047
-764
| -5% | -$90K | 0.3% | 72 |
|
|
2019
Q1 | $2.18M | Sell |
16,811
-222
| -1% | -$27K | 0.35% | 51 |
|
|
2018
Q4 | $1.97M | Sell |
17,033
-136
| -0.8% | -$15.2K | 0.35% | 53 |
|
|
2018
Q3 | $1.84M | Sell |
17,169
-485
| -3% | -$48.5K | 0.29% | 68 |
|
|
2018
Q2 | $1.51M | Sell |
17,654
-1,037
| -6% | -$85.2K | 0.24% | 88 |
|
|
2018
Q1 | $1.45M | Sell |
18,691
-1,421
| -7% | -$114K | 0.22% | 97 |
|
|
2017
Q4 | $1.7M | Sell |
20,112
-565
| -3% | -$48.1K | 0.26% | 82 |
|
|
2017
Q3 | $1.77M | Sell |
20,677
-718
| -3% | -$58.9K | 0.27% | 77 |
|
|
2017
Q2 | $1.76M | Sell |
21,395
-675
| -3% | -$55.1K | 0.27% | 76 |
|
|
2017
Q1 | $1.86M | Sell |
22,070
-1,010
| -4% | -$80.9K | 0.29% | 71 |
|
|
2016
Q4 | $1.7M | Sell |
23,080
-120
| -0.5% | -$8.94K | 0.26% | 83 |
|
|
2016
Q3 | $1.86M | Sell |
23,200
-18,766
| -45% | -$1.5M | 0.29% | 70 |
|
|
2016
Q2 | $3.31K | Sell |
41,966
-1,260
| -3% | -$94.9K | 0.25% | 94 |
|
|
2016
Q1 | $3.11M | Buy |
43,226
+764
| +2% | +$57.8K | 0.25% | 98 |
|
|
2015
Q4 | $3.58M | Buy |
42,462
+118
| +0.3% | +$9.79K | 0.3% | 79 |
|
|
2015
Q3 | $3.54M | Buy |
42,344
+9,440
| +29% | +$797K | 0.29% | 87 |
|
|
2015
Q2 | $2.75K | Sell |
32,904
-696
| -2% | -$53K | 0.41% | 59 |
|
|
2015
Q1 | $2.44K | Buy |
33,600
+3,645
| +12% | +$260K | 0.36% | 71 |
|
|
2014
Q4 | $2.07M | Sell |
29,955
-1,945
| -6% | -$131K | 0.29% | 76 |
|
|
2014
Q3 | $2.07M | Sell |
31,900
-1,125
| -3% | -$71.2K | 0.28% | 77 |
|
|
2014
Q2 | $2.05M | Sell |
33,025
-1,010
| -3% | -$60.3K | 0.28% | 74 |
|
|
2014
Q1 | $2M | Sell |
34,035
-2,017
| -6% | -$113K | 0.25% | 80 |
|
|
2013
Q4 | $1.84M | Buy |
36,052
+3,143
| +10% | +$157K | 0.22% | 89 |
|
|
2013
Q3 | $1.66M | Sell |
32,909
-1,256
| -4% | -$65.8K | 0.21% | 86 |
|
|
2013
Q2 | $1.68M | Buy |
+34,165
| New | +$1.86M | 0.21% | 95 |
|
Other funds holding LLY
Arden Trust's LLY Position: Q2 2024 in Review
Arden Trust reduced its Eli Lilly (LLY) stake by 6.9% in Q2 2024, selling an estimated $231K and leaving 3,886 shares worth $3.52M. The position accounts for 0.49% of the portfolio, ranked #38.
Arden Trust first reported a position in LLY in Q2 2013 and has held it in 45 quarters since. The position peaked at $3.58M in Q4 2015. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.
- Arden Trust held 3,886 shares of Eli Lilly worth $3.52M as of Q2 2024.
- Arden Trust sold 289 Eli Lilly shares in Q2 2024, an estimated $231K.
- Eli Lilly made up 0.49% of Arden Trust's portfolio in Q2 2024, its #38 holding.
- Arden Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 45 quarters since.
- Arden Trust's Eli Lilly position peaked at $3.58M in Q4 2015.
- 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.
Based on Arden Trust's 13F filing for Q2 2024, filed 9 Jul 2024.